epicenter of COVID-19 pandemic Genetically traced to market wildlife and viruses
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
-
-
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
-
Novavax 2024-2025 COVID-19 Vaccine Available at Major U.S. Pharmacies
On Sep. 13. 2024, Novavax announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to…
-
Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…
-
Scientists Sequenced Genome of Greenland Shark, world’s longest-living vertebrate
On Sept. 11, 2024, an international team of scientists led by the Leibniz Institute on Aging announced they…
-
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
-
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
-
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, with the nation in the midst of a summer surge of Covid-19 infections and…
-
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
-
City birds found to be carriers of antimicrobial resistant bacteria
On Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
-
University of Houston Researchers Created New Treatment and Vaccine for Flu and Various Coronaviruses
On Aug. 6, 2024, a team of researchers, led by the University of Houston, announced they had discovered…
-
BioNTech sued by UPenn over COVID-19 vaccine patent royalties
On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 2, 2024, the World Health Organization (WHO) announced results of a study that showed the introduction…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Plague | Vaccine | WHO
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
-
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 16, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine | Women's Health
Late-pregnancy RSV vaccination not associated with poor birth outcomes
On Jul. 8, 2024, a study reported that babies exposed to maternal RSV (respiratory syncytial virus) vaccination in…
-
Biotechnology | CDC | COVID-19 | Influenza | Vaccine
CDC Recommended Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season
On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
-
BARDA awarded up to $500 million in Project NextGen funding for vaccine clinical trials
On Jun. 13, 2024, the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic…
-
National Academies announced New Broad Definition of Long COVID
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
-
CSL Seqirus Signed an Agreement with the European Commission to Provide Pre-Pandemic Vaccines to the EU
On Jun. 11, 2024, CSL Seqirus was selected by the Health Emergency Preparedness and Response Authority (HERA), part…
-
COVID-19 | FDA | Therapeutics | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S Beginning in Fall 2024
On Jun. 5, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
-
Biotechnology | COVID-19 | FDA | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S. Beginning in Fall 2024
On June 5, 2024, the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee announced that it had…
-
COVID-19 eliminated a decade of progress in global level of life expectancy
On May 24, 2024, the World Health Organization (WHO) revealed that the COVID-19 pandemic reversed the trend of…
-
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
On May 17, 2024, researchers at Washington University School of Medicine in St. Louis announced a study had…
-
Novavax and Sanofi announced licensing agreement to co-commercialize COVID-19 vaccine and novel COVID-19-influenza combination vaccines
On May 10, 2024, Novavax announced that it had entered into a co-exclusive licensing agreement with Sanofi. The…
-
COVID vaccines not linked to seizures
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
-
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
-
National Academies reported COVID-19 vaccines don’t cause many potential harms
On Apr. 16, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
-
Study suggested staying current with COVID-19 vaccinations helped combat emerging variants
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
-
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued the an emergency use authorization for…
